Full Text View
Tabular View
No Study Results Posted
Related Studies
Paliperidone Extended Release (ER) in Schizophrenia Patients With a Duration of Illness Less Than 10 Years
This study has been completed.
Study NCT01362439   Information provided by Janssen-Cilag S.p.A.

First Received on May 26, 2011.   Last Updated on March 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Paliperidone ER
Additional drug interventions recognized in this trial
9-hydroxy-risperidone
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Janssen-Cilag S.p.A.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services